Ian Lipkin talks on his own long hauling experience with the coronavirus, and what he expects from the coronavirus in the future, as we cover Lipkin’s recent ME/CFS proteome study which identified a possible B-cell subset and biomarkers. Check all that out in...
There’s nothing like starting the new year with a new possibility. Following failures by scores of other researchers, Ian Lipkin and his new Serochip technology recently fingered the culprit behind the acute flaccid myeltis (AFM) outbreak that’s been...
The talk was titled, “Now for Something Completely Different: A microbe hunter turns to ME/CFS”. Except that Ian Lipkin is not just any microbe hunter: for many people, he’s THE microbe hunter. Internationally known for his breakthrough work on...
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...
For the first time ever in ME/CFS Ian Lipkin merged a gut microbiome and a metabolomics study together and came up with some surprising results. For one the differences in the gut microbiome were more profound than in the metabolome. For another the study suggested...
